caffeine and esmolol
caffeine has been researched along with esmolol in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fligner, DJ; Price, KR | 1 |
| Ramoska, EA; Richards, JR; Sand, IC | 1 |
| Chevillard, L; Grémain, V; Mégarbane, B; Saussereau, E; Schnell, G | 1 |
Reviews
1 review(s) available for caffeine and esmolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
7 other study(ies) available for caffeine and esmolol
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Treatment of caffeine toxicity with esmolol.
Topics: Adrenergic beta-Antagonists; Caffeine; Cardiac Complexes, Premature; Female; Humans; Infusions, Intravenous; Middle Aged; Propanolamines; Suicide, Attempted; Tachycardia, Supraventricular | 1990 |
Beta-blocker treatment of caffeine-induced tachydysrhythmias.
Topics: Adrenergic beta-Antagonists; Caffeine; Catecholamines; Humans; Propanolamines; Tachycardia, Ventricular; Vasoconstriction | 2016 |
Massive suicidal ingestion of caffeine: a case report with investigation of the cardiovascular effect/concentration relationships.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Adrenergic beta-1 Receptor Antagonists; Caffeine; Cardiotoxicity; Central Nervous System Stimulants; Electric Countershock; Half-Life; Heart Rate; Humans; Hyperlactatemia; Infusions, Intravenous; Intubation, Intratracheal; Male; Metabolic Clearance Rate; Middle Aged; Norepinephrine; Powders; Propanolamines; Suicide, Attempted; Tachycardia; Treatment Outcome; Ventricular Fibrillation | 2021 |